| scholarly article | Q13442814 |
| P50 | author | K. Rajender Reddy | Q69932454 |
| Herbert L Bonkovsky | Q90073250 | ||
| P2093 | author name string | Jose Serrano | |
| Robert J Fontana | |||
| Leonard B Seeff | |||
| Andrew Stolz | |||
| Huiman Barnhart | |||
| Jayant Talwalkar | |||
| Timothy Davern | |||
| Victor J Navarro | |||
| Raj Vuppalanchi | |||
| Averell H Sherker | |||
| Maricruz Vega | |||
| Lafaine Grant | |||
| P2860 | cites work | Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet | Q24642468 |
| HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin | Q29417159 | ||
| Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey | Q29547851 | ||
| Unconventional medicine in the United States. Prevalence, costs, and patterns of use | Q29615130 | ||
| Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. | Q30949867 | ||
| Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period | Q34440712 | ||
| Dietary supplement use in the United States, 2003-2006 | Q34493137 | ||
| Microbial contamination of medicinal plants--a review | Q34528302 | ||
| Usage patterns, health, and nutritional status of long-term multiple dietary supplement users: a cross-sectional study | Q34706461 | ||
| Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilis. | Q34880762 | ||
| Complementary and alternative therapies in prostate cancer. | Q35040040 | ||
| Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles | Q35085772 | ||
| Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs | Q36796350 | ||
| Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct | Q36799781 | ||
| Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States | Q36844723 | ||
| Factors Associated with Dietary Supplement Use among Healthy Adults of Five Ethnicities: The Multiethnic Cohort Study | Q37401886 | ||
| Side effects of anabolic androgenic steroids: pathological findings and structure-activity relationships. | Q37658575 | ||
| Hepatic Lesions Caused by Anabolic and Contraceptive Steroids | Q40130806 | ||
| Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries | Q40775438 | ||
| Screening methods for drugs and heavy metals in Chinese patent medicines | Q41744330 | ||
| Hepatotoxicity associated with the dietary supplement N.O.-XPLODE. | Q44238275 | ||
| Mass spectral analysis of PC-SPES confirms the presence of diethylstilbestrol. | Q44271801 | ||
| Why US adults use dietary supplements | Q44820645 | ||
| Mycotoxins in root extracts of American and Asian ginseng bind estrogen receptors alpha and beta. | Q44915453 | ||
| Dietary supplement use among infants, children, and adolescents in the United States, 1999-2002. | Q46972041 | ||
| Chinese proprietary medicine in Singapore: regulatory control of toxic heavy metals and undeclared drugs | Q47653449 | ||
| Toxic hepatitis in a group of 20 male body-builders taking dietary supplements. | Q48641987 | ||
| Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. | Q51206003 | ||
| Severe Hepatotoxicity Caused by a Methasteron-containing Performance-enhancing Supplement | Q59567828 | ||
| Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period | Q60344407 | ||
| Use of dietary supplements in the United States, 1988-94 | Q64131575 | ||
| Heavy metals in some Chinese herbal plants | Q72074367 | ||
| A study of western pharmaceuticals contained within samples of Chinese herbal/patent medicines collected from New York City's Chinatown | Q80671765 | ||
| Use and safety perceptions regarding herbal supplements: a study of older persons in southeast Idaho | Q83389280 | ||
| Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007 | Q84578388 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1399-1408 | |
| P577 | publication date | 2014-08-25 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network | |
| P478 | volume | 60 |
| Q41660660 | "Autoimmune(-Like)" Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis |
| Q89040693 | "…Not Intended to Diagnose, Treat, Cure or Prevent Any Disease." 25 Years of Botanical Dietary Supplement Research and the Lessons Learned |
| Q30566357 | A perspective on complementary/alternative medicine use among survivors of hematopoietic stem cell transplant: Benefits and uncertainties |
| Q98613722 | Acute Severe Liver Injury Related to Long-Term Garcinia cambogia Intake |
| Q48296572 | Acute liver failure induced by idiosyncratic reaction to drugs: Challenges in diagnosis and therapy |
| Q35614697 | Acute liver injury associated with a newer formulation of the herbal weight loss supplement Hydroxycut |
| Q47676260 | Adverse Effects of Nutraceuticals and Dietary Supplements |
| Q50052170 | Ayurvedic and herbal medicine-induced liver injury: It is time to wake up and take notice. |
| Q36010411 | Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome. |
| Q57163053 | Botanicals and Hepatotoxicity |
| Q54979918 | Breviscapine ameliorates CCl4‑induced liver injury in mice through inhibiting inflammatory apoptotic response and ROS generation. |
| Q46581797 | Characterization of chemical-induced sterile inflammation in vitro: application of the model compound ketoconazole in a human hepatic co-culture system |
| Q53504746 | Cholestatic liver injury secondary to artemisinin. |
| Q33917967 | Clinical Features and Outcomes of Complementary and Alternative Medicine Induced Acute Liver Failure and Injury |
| Q87866735 | Clinical outcomes, histopathological patterns, and chemical analysis of Ayurveda and herbal medicine associated with severe liver injury-A single-center experience from southern India |
| Q30954151 | Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™. |
| Q42180870 | Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis |
| Q45902096 | Development of a modified lymphocyte transformation test for diagnosing drug-induced liver injury associated with an adaptive immune response. |
| Q89174428 | Dietary supplements: What's in a name? What's in the bottle? |
| Q91809764 | Drug induced liver injury is associated with high mortality-A study from a tertiary care hospital in Pakistan |
| Q35819331 | Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk |
| Q39013635 | Drug-Induced Liver Injury Associated with Complementary and Alternative Medicines |
| Q61808214 | Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic |
| Q26767296 | Drug-Induced Liver Injury Network Causality Assessment: Criteria and Experience in the United States |
| Q94503833 | Drug-Induced Liver Injury in GI Practice |
| Q38824550 | Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature |
| Q36412863 | Drug-Induced Liver Injury: Pattern Recognition and Future Directions |
| Q52675513 | Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch? |
| Q95572129 | Drug-induced liver injury |
| Q30240121 | Drug-induced liver injury |
| Q30241050 | Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management |
| Q37748005 | Drug-induced liver injury: Do we know everything? |
| Q28468389 | Drug-induced liver injury: Towards early prediction and risk stratification |
| Q38331202 | Drug-induced liver injury: an overview over the most critical compounds |
| Q30235089 | Drug-induced liver injury: recent advances in diagnosis and risk assessment |
| Q35684831 | Drug-induced liver injury: results from the hospital-based Berlin Case-Control Surveillance Study |
| Q58594003 | Dysregulated Microbial Fermentation of Soluble Fiber Induces Cholestatic Liver Cancer |
| Q39820524 | Epigallocatechin gallate (EGCG) inhibits adhesion and migration of neural progenitor cells in vitro |
| Q35656015 | Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study |
| Q46349253 | First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans. |
| Q53458463 | Freshwater clam extract supplement-induced acute cholestasis. |
| Q88063155 | Guidelines for the Diagnosis and Management of Herb-Induced Liver Injury |
| Q91981353 | Hepatobiliary Events in Migraine Therapy with Herbs-The Case of Petadolex, A Petasites Hybridus Extract |
| Q40784338 | Hepatobiliary and pancreatic: Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients |
| Q35104128 | Hepatotoxic potential of asarones: in vitro evaluation of hepatotoxicity and quantitative determination in herbal products |
| Q55413223 | Hepatotoxicity Associated with Use of the Weight Loss Supplement Garcinia cambogia: A Case Report and Review of the Literature. |
| Q36804015 | Hepatotoxicity associated with the dietary supplement OxyELITE Pro™ - Hawaii, 2013. |
| Q36066011 | Hepatotoxicity associated with weight loss or sports dietary supplements, including OxyELITE Pro™ - United States, 2013. |
| Q26748911 | Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics |
| Q34462677 | Hepatotoxicity of herbal and dietary supplements: an update |
| Q64227701 | Herb induced liver injury after using herbal medicine: A systemic review and case-control study |
| Q56912365 | Herb-Induced Liver Injuries in Developing Nations: An Update |
| Q36512650 | Herb-Induced Liver Injury in the Berlin Case-Control Surveillance Study |
| Q26748874 | Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation |
| Q26764922 | Herbal Medicine in Mexico: A Cause of Hepatotoxicity. A Critical Review |
| Q39008344 | Herbal and Dietary Supplement-Induced Liver Injury |
| Q36299908 | Herbal dietary supplement associated hepatotoxicity: an upcoming workshop and need for research. |
| Q35531281 | Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps |
| Q36033537 | Herbal medicine-related hepatotoxicity |
| Q40096207 | Highlights of drug - and herb- induced liver injury in the literature from 2016: how best to translate new information into clinical practice? |
| Q38649906 | Idiosyncratic Drug Induced Liver Injury in African-Americans Is Associated With Greater Morbidity and Mortality Compared to Caucasians |
| Q100416670 | Impact of Herbal and Dietary Supplements Causing Drug-Induced Liver Injury in Latin America |
| Q57063824 | Impact of obesity on the toxicity of a multi-ingredient dietary supplement, OxyELITE Pro™ (New Formula), using the novel NZO/HILtJ obese mouse model: Physiological and mechanistic assessments |
| Q91656064 | Increasing impact of drug-induced liver injury |
| Q49885272 | International Comparison of Five Herbal Medicine Registration Systems to Inform Regulation Development: United Kingdom, Germany, United States of America, United Arab Emirates and Kingdom of Bahrain. |
| Q30405482 | Linoleic Acid Induced Acute Hepatitis: A Case Report and Review of the Literature. |
| Q90052856 | Liver Injury from Herbal and Dietary Supplements: An Introduction |
| Q26781749 | Liver Injury from Herbal, Dietary, and Weight Loss Supplements: a Review |
| Q48087951 | Liver injury and genetic polymorphisms in the cytochrome P450 and UDP-glucuronosyltransferase genes |
| Q33887186 | Liver injury from herbal and dietary supplements |
| Q46357787 | Liver toxicity mechanisms of herbs commonly used in Latin America. |
| Q37504121 | Metabolomic Study on Idiosyncratic Liver Injury Induced by Different Extracts of Polygonum multiflorum in Rats Integrated with Pattern Recognition and Enriched Pathways Analysis |
| Q47892086 | MicroRNAs as biomarkers for liver injury: Current knowledge, challenges and future prospects. |
| Q92377698 | Mitochondrial dysfunction as a mechanism of drug-induced hepatotoxicity: current understanding and future perspectives |
| Q51027472 | Natural history and outcomes in drug-induced autoimmune hepatitis. |
| Q91601505 | Patients' perceptions and use of natural health products |
| Q92535712 | Polygonum multiflorum-Induced Liver Injury: Clinical Characteristics, Risk Factors, Material Basis, Action Mechanism and Current Challenges |
| Q35655664 | Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system |
| Q88866277 | Prohibited Contaminants in Dietary Supplements |
| Q50223732 | Prolonged feeding with green tea polyphenols exacerbates cholesterol-induced fatty liver disease in mice. |
| Q40280676 | Proteomic Signature of Acute Liver Failure: From Discovery and Verification in a Pig Model to Confirmation in Humans |
| Q26771817 | RUCAM in Drug and Herb Induced Liver Injury: The Update |
| Q88644135 | Recent Advances in the Histopathology of Drug-Induced Liver Injury |
| Q30239062 | Research Advances on Hepatotoxicity of Herbal Medicines in China |
| Q55427610 | Retrospective Study of Reported Adverse Events Due to Complementary Health Products in Singapore From 2010 to 2016. |
| Q42175085 | Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK(®) Weight Loss Products: Results from the DILIN Prospective Study |
| Q47658710 | Safety assessment of the dietary supplement OxyELITE™ Pro (New Formula) in inbred and outbred mouse strains. |
| Q35490308 | Schisandrin B inhibits cell growth and induces cellular apoptosis and autophagy in mouse hepatocytes and macrophages: implications for its hepatotoxicity |
| Q26767376 | Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States |
| Q97071517 | Scientific opinion on the safety of green tea catechins |
| Q41881118 | Severe Acute Hepatocellular Injury Attributed to OxyELITE Pro: A Case Series |
| Q38332651 | Severe Cholestasis and Bile Acid Nephropathy From Anabolic Steroids Successfully Treated With Plasmapheresis |
| Q92751825 | Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors |
| Q92133470 | Severe liver injury due to herbal and dietary supplements and the role of liver transplantation |
| Q41985140 | Supplement-Induced Liver Injury |
| Q36830427 | Supplements and Hepatotoxicity |
| Q64072042 | Susceptibility-Related Factor and Biomarkers of Dietary Supplement -Induced Liver Injury in Rats |
| Q64975091 | The Contents of Herbal and Dietary Supplements Implicated in Liver Injury in the United States Are Frequently Mislabeled. |
| Q57066650 | The Development of a Database for Herbal and Dietary Supplement Induced Liver Toxicity |
| Q26752620 | The Honolulu Liver Disease Cluster at the Medical Center: Its Mysteries and Challenges |
| Q40181580 | The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware |
| Q57300045 | The Role of Polyphenols in Human Health and Food Systems: A Mini-Review |
| Q59353649 | The changing epidemiology of liver diseases in the Asia-Pacific region |
| Q31139774 | The incidence, presentation, outcomes, risk of mortality and economic data of drug-induced liver injury from a national database in Thailand: a population-base study |
| Q54964766 | The use of complementary and alternative medicine by patients with cancer: a cross-sectional survey in Saudi Arabia. |
| Q55470655 | Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury. |
| Q40326746 | Urgent Liver Transplantation for Dietary Supplements: An Under-Recognized Problem |
| Q55045913 | Usage, biological activity, and safety of selected botanical dietary supplements consumed in the United States. |
| Q90726862 | Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota |
| Q90387783 | Weight-loss supplementation and acute liver failure: the case of Garcinia Cambogia |
| Q47131682 | Yogi Detox Tea: A Potential Cause of Acute Liver Failure |
Search more.